ERANET-SCREAM.

ERANET LAC Project: Screening marine microalgae and terrestrial bacteria: in search of novel compounds of potential medicinal and other industrial values (SCREAM)

Thematic field: Bioeconomy

Topic: Screening bioactive metabolites & enzymes

(2016-2018)

Project Coordinator:

Norwegian Institute for Agricultural and Environmental Research, Norway

Dr.  Carl Spetz, mail: carl.spetzl@bioforsk.no

Partners:

1. Fraunhofer Chile Research, CHILE ( Dr. Lothar DRILLER)
2. BIODIATECH-Proplanta SRL Cluj-Napoca, ROMANIA ( Prof.Dr.Carmen SOCACIU)
3. Universidad Peruana Cayetano Heredia, Lima, PERU (Dr.Rosario ROJAS)

Aims and objectives:

The  four partners’ joined forces aim to develop a transnational  long-term  research  cooperation  platform  within  the  EU-Latin  America  Program  under  the  SCREAM project  proposal umbrella.

SCREAM targets a high impact scientific area, bio-discovery and the exploitation of marine microalgae and terrestrial  bacteria  as  renewable  sources  of  natural  bioactive  and  functional  components,  by  using  a  multidisciplinary  approach. Microalgae  species  will  include  Antarctic,  Arctic  and other  Nordic  species.  Bacteria  species  will  include  terrestrial acidophilic and acid tolerant species.

The studies will focus on:

• Microbiology of microalgae and bacteria,
• Fingerprinting their composition by ‘omics  technologies (metabolomics/proteomics),
• Their normal and stress-induced physiology
• Obtaining added value products from microalgae: concept, technology, product development and testing, economic

The  novelty  of  SCREAM  project derives  from  a  number  of original  and  innovative  activities  that  will  undoubtedly  lead  to  a  number  of  innovations, such as  cancer  research  and  functional  food  with  the  potential  for  further  exploitation.

By selecting microalgae as our main focus, SCREAM takes steps towards the future, targeting functional food products, not  only  for the  healthy  ingredients  supplied  by  the microalgae,  but  also  avoiding  use  of  overexploited agricultural fields.  Furthermore,  the  potential  of bioactive components from  microalgae  and/or  bacteria  in  anticancer  treatment is promising. Such molecules may affect the  tumor  cell  invasion  and  metastasis,  improving  long-term  therapeutic  success  of  conventional  anticancer agent by decreasing the possibility of chemo-resistance.

Other details about ERANet-LAC projects at:

http://eranet-lac.eu/about-eranet-lac.php

In order to strengthen the bi-regional partnership in Science, Technology and Innovation, ERANet-LAC is implementing two joint calls seeking to coordinate and cluster research programs. Furthermore, such projects will mutually open research infrastructures and coordinate and open innovation programmes.

ERANet-LAC will lay a special focus on the innovation dimension. It will seek to involve European and Latin American innovation agencies in the joint activities as well as in trust-building actions.

OUR RESULTS:

REPORT 2016 / RAPORT ETAPA 1/2016
Download Report

REPORT 2017 / RAPORT ETAPA 2/2017
Download Report

REPORT 2018 / RAPORT ETAPA 3/2018
Download Report

Partenerul roman PROPLANTA SRL  este finantat de catre Unitatea Executivă pentru Finanţarea Învăţământului Superior, a Cercetării, Dezvoltării şi Inovării (UEFISCDI) – Direcţia de Finanţare a Dezvoltării şi Inovării

Contract NR. 26 ⁄ 2016